Neocutis SA
Neocutis®
growth-factor and peptide skincare line
Neocutis is a Swiss-developed skincare line built around a proprietary ingredient the company calls PSP, short for Processed Skin Cell Proteins, a mixture of growth factors and other proteins produced by a laboratory-grown culture of skin cells. The company was founded in 2003, growing out of research at the University Hospital of Lausanne into whether substances made by cultured skin cells could help wounds heal. The cell culture behind PSP was established from a single donated human skin-tissue sample, and the company states that this one original donation continues to supply its manufacturing. Neocutis was acquired by the German pharmaceutical company Merz Pharma (marketed today through Merz Aesthetics) in 2013, and its products are sold as cosmetics, not as FDA-approved drugs.
The record
- Founded in 2003, based on research from the University Hospital of Lausanne, Switzerland.
- Acquired by Merz Pharma Group; the deal was announced July 31, 2013 and closed July 22, 2013.
- The PSP ingredient is manufactured from a cell line established from a single donated fetal skin-tissue sample; the company states this one donation supplies its ongoing manufacturing.
Where this came from
Also in skin treatments and skincare
Neocutis® and its logo belong to Neocutis SA (Switzerland); owned by Merz Pharma / Merz Aesthetics since 2013. This page describes equipment and products used at UDERMA Medspa & Laser; it is general information, not medical advice, and whether this one suits you is a conversation to have at a consultation.
Want to know if this is right for you?
UDERMA Medspa & Laser · 36426 US Hwy 19 N, Palm Harbor, FL · 727-569-6616
Book a consultation